Holen Sie sich die Stockscreener-App
29.83
1.57%
0.46
Handel nachbörslich:
29.83
Schlusskurs vom Vortag:
$29.37
Offen:
$29.6
24-Stunden-Volumen:
566.17K
Relative Volume:
0.85
Marktkapitalisierung:
$1.40B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-64.85
EPS:
-0.46
Netto-Cashflow:
$151.63M
1W Leistung:
+3.43%
1M Leistung:
-5.00%
6M Leistung:
-35.97%
1J Leistung:
-6.22%
1-Tages-Spanne:
$29.18
$30.06
1-Wochen-Bereich:
$28.10
$30.06
52-Wochen-Spanne:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
29.83 | 1.35B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
279.04 | 38.38B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
54.43 | 10.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.98 | 8.67B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.94 | 9.63B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
38.56 | 6.61B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Pharmacy Automation Market in 2025-2032 Detailed Study - openPR.com
Opportunities for the Global Medication Management Solutions - openPR.com
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Omnicell stock holds $40 target amid tariff cuts By Investing.com - Investing.com Nigeria
Omnicell stockholders approve equity plan amendment - Investing.com Australia
Omnicell stock rises on prospects of improved profitability due to U.S.-China trade truce, buyback - MSN
Omnicell stockholders approve equity plan amendment By Investing.com - Investing.com Nigeria
Omnicell Stockholders Approve Key Proposals at Annual Meeting - TipRanks
What Analysts Are Saying About Omnicell Stock - Benzinga
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | - GuruFocus
Omnicell (OMCL): Wells Fargo Raises Price Target to $37, Maintains Overweight Rating | OMCL Stock News - GuruFocus
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stoc - GuruFocus
Piper Sandler Adjusts Omnicell Price Target to $57 From $46, Maintains Overweight Rating - marketscreener.com
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback N - GuruFocus
Wells Fargo Boosts Price Target for Omnicell (OMCL) Amid Improved Outlook | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback News | OMCL Stock News - GuruFocus
Omnicell, Inc. authorizes a Buyback Plan. - marketscreener.com
Omnicell Raises Earnings Forecast Amid Lower China Tariffs - Finimize
Omnicell Stock Jumps 5.9% on Strong Profit Guidance and China Tariff CutsNews and Statistics - IndexBox
BofA lifts Omnicell stock price target to $34 from $30 - Investing.com Australia
BofA lifts Omnicell stock price target to $34 from $30 By Investing.com - Investing.com Nigeria
Why Omnicell (OMCL) Stock Is Trading Up Today - Yahoo Finance
Omnicell upgraded at Wells Fargo on positive risk-reward setup - MSN
Omnicell Inc (OMCL) Shares Down 3.27% on May 21 - GuruFocus
Omnicell (OMCL) Adjusts Q2 Revenue and EBITDA Guidance | OMCL St - GuruFocus
Omnicell Updates Q2, 2025 Earnings Guidance, Approves New $75 Million Share Buyback Plan - marketscreener.com
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Pla - GuruFocus
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Plan | OMCL Stock News - GuruFocus
Omnicell (OMCL) Updates FY25 Outlook Amid Tariff Reductions | OM - GuruFocus
Omnicell Updates 2025 Guidance and Stock Buyback Plan - TipRanks
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program - BioSpace
Omnicell Expects Improved Profitability, Updates Second Quarter - GuruFocus
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program | OMCL Stock News - GuruFocus
How the Pharmacy Automation Market Will Evolve by 2032Growth, - openPR.com
Omnicell Surpasses Q1 2025 Revenue Expectations Amidst Future ChallengesNews and Statistics - IndexBox
OMCL Q1 Earnings Call: Revenue Tops Expectations but Tariff Headwinds Pressure Profit Outlook - Yahoo Finance
Omnicell opens innovation lab in Texas - MSN
Omnicell launches RFID products for medication management - Investing.com Australia
Omnicell (OMCL) Unveils New Solutions to Optimize Healthcare Wor - GuruFocus
Omnicell's New Perioperative Clinic Setting Products May Boost Stock - Yahoo Finance
AI companies target Central Texas in latest tech scene shakeup - MySA
Omnicell launches RFID products for medication management By Investing.com - Investing.com Nigeria
3 Hated Stocks Skating on Thin Ice - Yahoo Finance
Omnicell (OMCL) Receives Upgraded Rating and Price Target Increa - GuruFocus
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.85%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):